ENTITY
Nektar Therapeutics

Nektar Therapeutics (NKTR US)

8
Analysis
Health CareUnited States
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.
more
Refresh
09 Nov 2023 05:00 • Upcoming
Add To Calendar

Q3 2023

Company Call
Share
13 Sep 2023 23:00 • Latest

Status Update

Company Call
Share
09 Aug 2023 05:00

Q2 2023

Company Call
Share
10 May 2023 05:00

Q1 2023

Company Call
Share
No more events
x